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eukaryotic chromosomes, which keep the cell's genomic stability and
integrity. Because conventional DNA polymerases cannot replicate the
very ends of linearized DNA, telomeric sequence (TTAGGG repeat
arrays) is gradually lost during cell division and aging. For example, nor-
mal peripheral bloodmononuclear cells loose up to about 100-base pair
telomeric sequence per year (Iwama et al., 1998). Deregulation of
telomere length is associated with various diseases: accelerated telo-
mere shortening exacerbates premature aging in the patients with
Werner and Hutchinson–Gilford progeria syndromes, whereas inefﬁ-
cient telomeremaintenance in the patients with dyskeratosis congenita
causes bone marrow failure. Premalignant hyper-proliferative lesions
give rise to shortened telomeres, which are eventually stabilized by
telomerase-mediated telomere replenishment in cancer. Accordingly,
telomere length is referred to not only as a “mitotic clock”, which counts
the number of normal cell division, but also as a biological marker of
aging. Recently, telomere length has also been established as a surrogate
marker for disease and lifestyle: shortened leukocyte telomeres are
associated with a wide range of threat to life, including cardiovascular
disease and psychological stresses (Haycock et al., 2014; Lin et al.,
2012).
Strictly speaking, however, telomeric TTAGGG repeats per se are not
the caps for stabilizing the chromosome ends. In fact, the farthest end of
the double-stranded telomeric DNA consists of a 50–300-nucleotide
single-stranded tract, called 3′-overhang or G-tail (guanine-rich
strand-tail), which provides a molecular basis for the chromosome
end capping. Telomere G-tail folds back to form a protective “t-loop”
by means of strand invasion at the double-stranded telomere DNA
(Grifﬁth et al., 1999). This lariat structure masks the chromosome end
from being recognized as damage. Genetic manipulation that disrupts
telomere G-tails (e.g., knockout of telomeric repeat-binding factor
2) promptly compromises the end protection, eliciting DNA damage re-
sponse even if the cells retain long telomeres (Celli and de Lange, 2005).
This suggests that G-tail length rather than the total telomere length,
more directly contributes to or correlates with pathogenesis. But until
recently, whether or not this is the case in the clinical settings has
remained elusive. In this issue of EBioMedicine, using a highly sensitive
and quantitative method, Nezu, Tahara and colleagues quantitated
both G-tail and total telomere length of leukocytes in patients with aDOI of original article: http://dx.doi.org/10.1016/j.ebiom.2015.05.025.
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rather than total telomere length, is associated with endothelial func-
tion and severity of age-related white matter changes. Thus, shorter
G-tail predicts higher disease risk.
Nezu et al.'s paper highlights three aspects. First, the authors discov-
ered a non-invasive surrogate marker that could predict an increased
risk of future cardiovascular disease, stroke, dementia, and death. Sec-
ond, while telomere dysfunction in late generations of telomerase
knockoutmice gives a severe deleterious impact on highly regenerative
tissues (Lee et al., 1998), this study focused on the diseases associated
with non-regenerative/post-mitotic tissues (i.e., heart and brain) and
identiﬁed G-tail, the telomere-related parameter, as the predictive
disease marker. Third, their observations are consistent with the
established concept in telomere biology that G-tail is a sticking tab for
t-loop and therefore, plays more fundamental role in the end capping
than the double-stranded telomere DNA. In laboratories, total telomere
length has been more commonly measured than G-tail length by using
conventional methods, such as Southern blotting, polymerase chain re-
action, and ﬂuorescence in situ hybridization. Relative uncommonness
of G-tail studies might be in part due to technical issues such that G-
tail measurement needs to be performed under the non-denatured
experimental conditions that detect only the single-stranded DNA.
Nezu and colleagues successfully employed the hybridization protec-
tion assay (HPA) method (Tahara et al., 2005), which allows sensitive
and quantitative detection of G-tail.
According to their observations, G-tail length decreases with age
(Nezu et al., 2015). This would be in agreement with previous observa-
tions that telomere shortening is accompanied by G-tail shortening.
Strikingly, however, their analyses demonstrate thatG-tail length rather
than total telomere length is an independent biomarker for endothelial
dysfunction and white matter lesions. This fact suggests that G-tail is a
nimbler sensor than the entire telomeres for pathological stresses. In
other words, G-tail length could ﬂuctuate upon exposure to various
stresses. Indeed, G-tail is also shortened in hemodialysis patients
(Hirashio et al., 2014). Mechanistically, factors that could modulate G-
tail length include telomerase-mediated G-strand extension, end resec-
tion of the antisense C-strand, formation and resolution of higher-order
structure called G-quadruplexes, loading of the shelterin protein com-
plexes and innate hypersensitivity to oxidative stress. Meanwhile, a re-
cent study indicates that telomere DNA is transcribed to a non-coding
RNA called TERRA, which is implicated in genome-wide alteration of
gene expression in human cancer cells in vivo (Hirashima and Seimiya,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
805H. Seimiya / EBioMedicine 2 (2015) 804–8052015). It is of interest how these telomere-related parameters affect G-
tail dynamics and cell fate under pathological stress conditions. Because
the sample size in Nezu et al.'s study is small, it would be necessary to
perform large-scale, prospective studies to measure G-tail length in
both patient and control populations. Such studieswill further elucidate
cryptic linkages between G-tail length and health problems.
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